Gene Expression and Chondrogenic Potential of Cartilage Cells: Osteoarthritis Grade Differences

Int J Mol Sci. 2022 Sep 13;23(18):10610. doi: 10.3390/ijms231810610.

Abstract

Recent data suggest that cells isolated from osteoarthritic (OA) cartilage express mesenchymal progenitor cell (MPC) markers that have the capacity to form hyaline-like cartilage tissue. Whether or not these cells are influenced by the severity of OA remains unexplored. Therefore, we analyzed MPC marker expression and chondrogenetic potential of cells from mild, moderate and severe OA tissue. Human osteoarthritic tibial plateaus were obtained from 25 patients undergoing total knee replacement. Each sample was classified as mild, moderate or severe OA according to OARSI scoring. mRNA expression levels of MPC markers-CD105, CD166, Notch 1, Sox9; mature chondrocyte markers-Aggrecan (Acan), Col II A1, hypertrophic chondrocyte and osteoarthritis-related markers-Col I A1, MMP-13 and ALPL were measured at the tissue level (day 0), after 2 weeks of in vitro expansion (day 14) and following chondrogenic in vitro re-differentiation (day 35). Pellet matrix composition after in vitro chondrogenesis of different OA-derived cells was tested for proteoglycans, collagen II and I by safranin O and immunofluorescence staining. Multiple MPC markers were found in OA cartilage resident tissue within a single OA joint with no significant difference between grades except for Notch1, which was higher in severe OA tissues. Expression levels of CD105 and Notch 1 were comparable between OA cartilage-derived cells of different disease grades and bone marrow mesenchymal stem cell (BM-MSC) line (healthy control). However, the MPC marker Sox 9 was conserved after in vitro expansion and significantly higher in OA cartilage-derived cells compared to its levels in the BM-MSC. The in vitro expansion of cartilage-derived cells resulted in enrichment while re-differentiation in reduction of MPC markers for all three analyzed grades. However, only moderate OA-derived cells after the in vitro chondrogenesis resulted in the formation of hyaline cartilage-like tissue. The latter tissue samples were also highly positive for collagen II and proteoglycans with no expression of osteoarthritis-related markers (collagen I, ALPL and MMP13). MPC marker expression did not differ between OA grades at the tissue level. Interestingly after in vitro re-differentiation, only moderate OA-derived cells showed the capacity to form hyaline cartilage-like tissue. These findings may have implications for clinical practice to understand the intrinsic repair capacity of articular cartilage in OA tissues and raises the possibility of these progenitor cells as a candidate for articular cartilage repair.

Keywords: cartilage mesenchymal progenitor cells; cartilage repair; osteoarthritis.

MeSH terms

  • Aggrecans / metabolism
  • Cartilage, Articular* / metabolism
  • Cell Differentiation / genetics
  • Cells, Cultured
  • Chondrocytes / metabolism
  • Chondrogenesis / genetics
  • Gene Expression
  • Humans
  • Matrix Metalloproteinase 13 / metabolism
  • Osteoarthritis* / genetics
  • Osteoarthritis* / metabolism
  • Proteoglycans / genetics
  • Proteoglycans / metabolism
  • RNA, Messenger / metabolism

Substances

  • Aggrecans
  • Proteoglycans
  • RNA, Messenger
  • Matrix Metalloproteinase 13

Grants and funding

This research received no external funding.